References
- Rizzo A, Maibach H. Expression profiling to individualize dermatologic therapy. J Dermatol Treat. 2012;23:161–7
- Kitts A, Sherry S. The Single Nucleotide Polymorphism Database (dbSNP) of nucleotide sequence variation. In: McEntyre J, Ostell J, eds. The NCBI Handbook [Internet], Chapter 5. Bethesda (MD): National Center for Biotechnology Information (US), 2002. Available from http://www.ncbi.nlm.nih.gov/books/NBK21088/ [2002 Oct 9; Updated 2011 Feb 2]
- Dudley J, Karczewski J. Exploring Personal Genomics, 1st ed. Oxford: Oxford UP, 2013
- Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nature Methods. 2010;7:248–9
- Tatonetti NP, Dudley JT, Sagreiya H, et al. An integrative method for scoring candidate genes from association studies: application to warfarin dosing. BMC Bioinformatics. 2010;11:S9
- Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;366:707–14
- Hatzivassiliou G, Song K, Yen I, et al. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature. 2010;464:431–5
- Flaherty KT, Robert C. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med. 2012;367:104–14
- Hitt, E. Novel Agents Revolutionize Melanoma Treatment. New Jersey: OncLive, 2013. Available from http://www.onclive.com/publications/obtn/2013/August-2013/Novel-Agents-Revolutionize-Melanoma-Treatment Last accessed Sept 19, 2013
- National Cancer Institute: PDQ® Melanoma Treatment. Bethesda, MD: National Cancer Institute. Date last modified <5/16/2013>. Availablefrom http://cancer.gov/cancertopics/pdq/treatment/melanoma/HealthProfessional. Accessed October 9, 2013
- Henkin RI. Vismodegib in advanced basal cell carcinoma. N Engl J Med. 2012;367:970–1
- Grealy RE, Griffiths LY. Current status of pharmacogenomics testing for anti-tumor drug therapies. Mol Diag Theory. 2009;13:65–72
- Greenfield NP, Maibach HI. Pharmacogenomic biomarkers in dermatologic drugs. J Dermatol Treat 2012. Epub ahead of print
- Wolverton SE, Jonathan KW. Systemic Drugs for Skin Diseases, 1st ed. Philadelphia: Saunders, 1991
- Katzung BG, Masters SU, Trevor AN, . Basic & Clinical Pharmacology, 12th ed. New York: McGraw-Hill Medical, 2011
- Wishart DS, Knox C, Guo AC, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668–72